WEP Clinical (WEP) is excited to announce that it is moving its US office location, due to a period of rapid growth and development for the company. Come September 18, 2017, the new WEP [...]

WEP Clinical, a global pharmaceutical and services company, and MendeliKABS Inc., a Canadian pharmaceutical company dedicated to the treatment of rare diseases, announce an exclusive Named Patient agreement to commercialise MDK-Nitisinone (nitisinone), a drug for [...]